SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)

Clinical trial NCT05141201 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05141201
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Lupus Erythematosus, Systemic

Start date: 2021-12-21
Primary completion: 2027-03-31
Enrollment: 1620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.